Moreover, a recent study revealed that TXNIP deletion alleviates hepatic steatosis and inflammatory responses in a mouse model of non-alcoholic steatohepatitis (NASH) [13]. The gene discussed is TXNIP; the disease is metabolic dysfunction-associated steatohepatitis.